The role of Wnt signaling pathway in carcinogenesis and implications for anticancer therapeutics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The role of Wnt signaling pathway in carcinogenesis and implications for anticancer therapeutics ; volume:12 ; number:1 ; day:22 ; month:4 ; year:2014 ; pages:1-4 ; date:12.2014
Hereditary cancer in clinical practice ; 12, Heft 1 (22.4.2014), 1-4, 12.2014
- Creator
-
Sheikh, Asfandyar
- Contributor
-
Niazi, Asfandyar Khan
Ahmed, Muhammad Zafar
Iqbal, Bushra
Anwer, Syed Muhammad Saad
Khan, Hira Hussain
SpringerLink (Online service)
- DOI
-
10.1186/1897-4287-12-13
- URN
-
urn:nbn:de:1111-201607102510
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sheikh, Asfandyar
- Niazi, Asfandyar Khan
- Ahmed, Muhammad Zafar
- Iqbal, Bushra
- Anwer, Syed Muhammad Saad
- Khan, Hira Hussain
- SpringerLink (Online service)
Other Objects (12)
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
Wnt/beta-catenin pathway: modulating anticancer immune response
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics
The Wnt/beta-catenin pathway in gastrointestinal development, homeostasis, and carcinogenesis
Targeting CDK9 for anti-cancer therapeutics
Cholecystectomy promotes colon carcinogenesis by activating the Wnt signaling pathway by increasing the deoxycholic acid level
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer
Correction: Cholecystectomy promotes colon carcinogenesis by activating the Wnt signaling pathway by increasing the deoxycholic acid level
PARP inhibitors: current status and implications for anticancer therapeutics
Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
Wnt/beta-catenin pathway: modulating anticancer immune response
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics
The Wnt/beta-catenin pathway in gastrointestinal development, homeostasis, and carcinogenesis
Targeting CDK9 for anti-cancer therapeutics
Cholecystectomy promotes colon carcinogenesis by activating the Wnt signaling pathway by increasing the deoxycholic acid level
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer
Correction: Cholecystectomy promotes colon carcinogenesis by activating the Wnt signaling pathway by increasing the deoxycholic acid level
PARP inhibitors: current status and implications for anticancer therapeutics
Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
Wnt/beta-catenin pathway: modulating anticancer immune response
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics
The Wnt/beta-catenin pathway in gastrointestinal development, homeostasis, and carcinogenesis
Targeting CDK9 for anti-cancer therapeutics
Cholecystectomy promotes colon carcinogenesis by activating the Wnt signaling pathway by increasing the deoxycholic acid level
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer
Correction: Cholecystectomy promotes colon carcinogenesis by activating the Wnt signaling pathway by increasing the deoxycholic acid level
PARP inhibitors: current status and implications for anticancer therapeutics
Biocompatible nanoreactors of catalase and nanozymes for anticancer therapeutics